NeuroOne(R) Receives FDA 510(k) Clearance for OneRF(R) Trigeminal Nerve Ablation System to Treat Facial Pain
NeuroOne(R) Receives FDA 510(k) Clearance for OneRF(R) Trigeminal Nerve Ablation System to Treat Facial Pain GlobeNewswire August 18, 2025 FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) — NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical […]